XML 56 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Notes to the interim condensed consolidated statement of financial position - Financial debt - Derivatives (Details)
6 Months Ended 12 Months Ended
Mar. 25, 2024
shares
Jan. 04, 2024
EUR (€)
€ / shares
shares
Nov. 28, 2022
EUR (€)
D
€ / shares
shares
Jul. 01, 2022
€ / shares
shares
Jun. 30, 2024
EUR (€)
shares
€ / shares
Dec. 31, 2023
EUR (€)
shares
Jan. 03, 2024
€ / shares
Disclosure of detailed information about borrowings [line items]              
Number of equity instruments granted 300,000            
Finance contract with EIB, Tranche A              
Disclosure of detailed information about borrowings [line items]              
Number of BSA outstanding     2,266,023   2,266,023 2,266,023  
Number of shares per instrument     1.00   1.27 1.20  
Stock price (€)     4.13   2.79 4.10  
Maturity (years)     12 years   10 years 4 months 24 days 10 years 10 months 24 days  
Volatility     68.00%   59.60% 62.00%  
Cap of the put option (m€)     25.0   25.0 25.0  
Fair Value (k€) | €     € 9,469,000   € 6,738,000 € 10,266,000  
Unit fair value     0.0418   0.0297 0.0453  
Finance contract with EIB, Tranche B              
Disclosure of detailed information about borrowings [line items]              
Percentage of company's share capital outstanding, issued as warrants   6.07%          
Exercise price of warrant | € / shares   € 3.95         € 3.95
Number of BSA outstanding   3,144,654     3,144,654    
Number of shares per instrument   1.00     1.00    
Stock price (€) | € / shares   4.12     2.79    
Maturity (years)   12 years     11 years 6 months    
Volatility   62.00%     59.60%    
Cap of the put option (m€)   25.0     25.0    
Fair Value (k€) | €   € 11,809,000     € 6,830,000    
Unit fair value | €   0.0376     0.0217    
BSA 2022              
Disclosure of detailed information about borrowings [line items]              
Number of equity instruments granted         2,266,023    
Subscription premium price per share (€) | € / shares         € 0.01    
Exercise price (in euros) | € / shares         € 4.02    
Number of shares per instrument         1    
BSA 2024 [Member]              
Disclosure of detailed information about borrowings [line items]              
Number of equity instruments granted         3,144,654    
Subscription premium price per share (€) | € / shares         € 0.01    
Exercise price (in euros) | € / shares         € 3.95    
Number of shares per instrument         1    
Warrant agreement with the European Investment Bank              
Disclosure of detailed information about borrowings [line items]              
Term over which volume weighted average price per share to determine number of warrants to be issued       180 days      
Maturity term of warrants   12 years          
Warrant agreement with the European Investment Bank | Ordinary shares              
Disclosure of detailed information about borrowings [line items]              
Number of shares per instrument           1.20  
Warrant agreement with the European Investment Bank | Derivatives              
Disclosure of detailed information about borrowings [line items]              
Threshold trading days of warrants | D     90        
Subscription premium price per share (€) | € / shares       € 0.01      
Maturity term of warrants       12 years      
Number of shares per AGA       1      
Warrant agreement with the European Investment Bank | Derivatives | Finance contract with EIB, Tranche A              
Disclosure of detailed information about borrowings [line items]              
Number of warrants issued     2,266,023        
Percentage of company's share capital outstanding, issued as warrants     4.70%        
Exercise price of warrant | € / shares     € 4.0152        
Maximum potential gross proceeds from exercise of warrants | €     € 9,100,000        
Transaction costs on issue of warrants | €     € 56,000        
Warrant agreement with the European Investment Bank | Derivatives | Finance contract with EIB, Tranche B              
Disclosure of detailed information about borrowings [line items]              
Number of warrants issued   3,144,654          
Percentage of company's share capital outstanding, issued as warrants   5.20%          
Exercise price of warrant | € / shares   € 3.95          
Maximum potential gross proceeds from exercise of warrants | €   € 12,400,000          
Transaction costs on issue of warrants | €   € 90,000